We have located links that may give you full text access.
Benign lymphoepithelial parotid lesions in HIV-positive patients: spectrum of findings at gray-scale and Doppler sonography.
AJR. American Journal of Roentgenology 1995 October
OBJECTIVE: Benign lymphoepithelial lesions are intraparotid nodules that develop as an early manifestation of HIV infection. The purpose of this study was to describe the spectrum of sonographic and Doppler findings of benign lymphoepithelial lesions in HIV-positive patients and to assess whether these findings are specific for the diagnosis of such lesions.
SUBJECTS AND METHODS: Nine HIV-positive patients with swelling of the parotid gland caused by single or multiple parotid nodules were evaluated. Fourteen nodules were identified sonographically and proved to be benign lymphoepithelial lesions at cytologic examination. They were assessed with gray-scale, duplex, color Doppler, and power Doppler sonography. For each nodule, the echogenicity, grade and pattern of vascularity, and spectral tracings were evaluated.
RESULTS: Benign lymphoepithelial lesions manifested as parotid nodules with a wide spectrum of sonographic appearances, ranging from simple cysts to mixed masses with predominantly solid components. Cystic lesions (10/14) were not purely anechoic; they had an internal network of thin septa supplied by vessel pedicles and, in four of 10 cases, a solid mural nodule. On the other hand, mixed nodules (4/14) had a higher conspicuity of solid tissue and thicker stromal septa, thus resembling a parotid neoplasm more than a cyst. The overall grade of vascularity of benign lymphoepithelial lesions varied from avascular to intensely hypervascular. Generally, mixed nodules were more hypervascular than were the cystlike ones. Spectral analysis showed slow velocity (peak systolic velocity range, 8-28 cm/sec; mean, 20 20 cm/sec) and low impedance (resistive index range, 0.36-0.70; mean, 0.57) arterial flows.
CONCLUSION: The spectrum of sonographic and Doppler features of benign lymphoepithelial lesions in HIV-positive patients is broad. Sonographic findings are non-specific for the diagnosis of such lesions, especially in cases of mixed solid-cystic isolated nodules.
SUBJECTS AND METHODS: Nine HIV-positive patients with swelling of the parotid gland caused by single or multiple parotid nodules were evaluated. Fourteen nodules were identified sonographically and proved to be benign lymphoepithelial lesions at cytologic examination. They were assessed with gray-scale, duplex, color Doppler, and power Doppler sonography. For each nodule, the echogenicity, grade and pattern of vascularity, and spectral tracings were evaluated.
RESULTS: Benign lymphoepithelial lesions manifested as parotid nodules with a wide spectrum of sonographic appearances, ranging from simple cysts to mixed masses with predominantly solid components. Cystic lesions (10/14) were not purely anechoic; they had an internal network of thin septa supplied by vessel pedicles and, in four of 10 cases, a solid mural nodule. On the other hand, mixed nodules (4/14) had a higher conspicuity of solid tissue and thicker stromal septa, thus resembling a parotid neoplasm more than a cyst. The overall grade of vascularity of benign lymphoepithelial lesions varied from avascular to intensely hypervascular. Generally, mixed nodules were more hypervascular than were the cystlike ones. Spectral analysis showed slow velocity (peak systolic velocity range, 8-28 cm/sec; mean, 20 20 cm/sec) and low impedance (resistive index range, 0.36-0.70; mean, 0.57) arterial flows.
CONCLUSION: The spectrum of sonographic and Doppler features of benign lymphoepithelial lesions in HIV-positive patients is broad. Sonographic findings are non-specific for the diagnosis of such lesions, especially in cases of mixed solid-cystic isolated nodules.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app